TheraVac Biologics headquarters details
- Street address
- 101 Broadway Blvd. Lobo Rainforest Bldg. NE Suite 1100
- City
- Albuquerque
- State / region
- New Mexico
- ZIP / postal code
- 87102
- Country
- United States
- Phone
- +1 647 830 6790
- Website
- theravacbio.com
Location map
Open in Google MapsAll TheraVac Biologics office locations
| City | State / region | Country | Type |
|---|---|---|---|
| Albuquerque HQ | New Mexico | United States | Headquarters |
Showing the headquarters of 2 recorded locations. See every location in GraphIQ →
About TheraVac Biologics
TheraVac Biologics is headquartered in Albuquerque, New Mexico, United States. The company has 2 recorded locations and employs approximately 6 people worldwide.
Where is TheraVac Biologics's main office?
TheraVac Biologics's main headquarters office is located at 101 Broadway Blvd. Lobo Rainforest Bldg. NE Suite 1100, Albuquerque, New Mexico 87102, United States. This is the company's primary corporate address.
TheraVac Biologics contact information
The main switchboard for TheraVac Biologics headquarters can be reached at +1 647 830 6790. Official website: theravacbio.com.
What does TheraVac Biologics do?
TheraVac Biologics develops immunotherapies for diseases involving misfolded proteins and chronic inflammation.
Frequently asked questions
Where is TheraVac Biologics headquarters?
TheraVac Biologics's headquarters is located at 101 Broadway Blvd. Lobo Rainforest Bldg. NE Suite 1100, Albuquerque, New Mexico 87102, United States.
How many offices does TheraVac Biologics have?
GraphIQ records 2 locations for TheraVac Biologics, as of October 2026.
What is TheraVac Biologics's corporate address?
The corporate headquarters address is 101 Broadway Blvd. Lobo Rainforest Bldg. NE Suite 1100, Albuquerque, New Mexico 87102, United States.
What is TheraVac Biologics's phone number?
The main phone number for TheraVac Biologics headquarters is +1 647 830 6790.
How many employees does TheraVac Biologics have?
TheraVac Biologics has approximately 6 employees (GraphIQ estimate, 2026).